Buck Wealth Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Buck Wealth Strategies’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86K	Buy	+452	New	+$77.7K	0.01%	275

Other funds holding IBB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AFG

Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

Buck Wealth Strategies's IBB Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 452 shares worth $86K. The stake represents 0.01% of the portfolio and ranks #275 among its holdings.

611 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Buck Wealth Strategies held 452 shares of iShares Biotechnology ETF worth $86K as of Q2 2026.
iShares Biotechnology ETF was a new Buck Wealth Strategies position in Q2 2026.
iShares Biotechnology ETF made up 0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #275 holding.
611 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.